| Views | |
|---|---|
| Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing | 99 |
| October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing | 4 | 4 | 17 | 4 | 2 | 4 | 0 |
| Views | |
|---|---|
| 2021_Jurmeister_etal.pdf | 44 |
